Connect with us


John Deere OR Mahindra Tractor: Which one to choose?



John Deere

Defining best simply by brand and HP is tough, least to say. There are many other factors that play significant roles in deciding the better option, may include customer usage or driving ability. If, for instance, you choose to base your decision upon price, both are usually priced equally; for example, if you search Mahindra 575 di Price 2022 and John Deere 3028EN Price, both are similarly set in the market, but Mahindra comes at 2WD while John Deere at 4WD specification.

Both the companies are well-respected and have their brand in the agriculture machine industry, competing with each other just like we saw with the Mahindra 575 di Sarpanch Price 2022 and John Deere 3028EN Price.  

Let’s get to know both the companies a little bit more:

Company’s Overview


Mahindra Tractors is an Indian agricultural vehicle manufacturer that is a part of Mahindra & Mahindra. Mahindra overtook Ford as the top-selling tractor brand globally in 2010. India and China have the greatest populations of Mahindra customers but have expanding markets in Australia and North America as well. With a production rate of 150,000 tractors annually, the firm is the biggest tractor producer in India.


John Deere is an essential American industrial and farm equipment producer. Its main headquarters is in Moline, Illinois. The company was launched in 1836 by John Deere, who created one of the first steel ploughs capable of tilling prairie soil in America without clogging. The plough was manufactured and marketed by Deere’s company the following year, which he then incorporated as Deere & Company in 1868. Deere & Company has been led by five generations of the Deere family since its founding.

  • What is the starting price of Mahindra and John Deere Tractors?

Now that we are aware of the companies, let’s look into the starting point of their product range.

MAHINDRA TRACTORS – Mahindra Tractors offers over 66+ tractor models with an HP range of 15-75 within the Indian market. You can find the starting price of Mahindra Tractors in India at Rs 3.05Lakh.

JOHN DEERE – John Deere offers over 57+ tractor models with an HP range of 28-120 within the Indian market. You can find the starting price of John Deere tractors in India at Rs 5.60Lakh.

  • What are the warranty policies?

Let’s move on to the warranty policies section of each company.


Mahindra Tractors provide the following warranties over 4 different product categories: 


  • All tractors come with a 3-Year/2000-Hour Extended Engine and Power Train Warranty.
  • This includes all components completely enclosed within the engine’s crankcase, pan, cylinder head, rocker arm cover, timing gear cover, and other related elements.
  • The powertrain includes the clutch assembly but not the transmission, final drives, drive axles, differentials, front axles, power take-off, and clutch housings and components contained therein.


  • A 2-Year/1000-Hour Warranty applies to each loader component.
  • A 1-Year/1000 Warranty applies to all hydraulic parts, buckets and other loader attachments. 


  • A 1-Year/1000-Hour Hour Warranty covers all backhoe components, but ordinary wear and tear items are not covered.


  • All mid-mount mowers come with a 1-Year/500-Hour Warranty. Regularly replaceable service items such as oils, lubricants, coolants, filters, clutch and brake discs, and brake linings are not covered by this warranty, nor are parts covered by the warranties offered by the respective manufacturers. Additionally, the following items are not included: belts, hoses, glass, lightbulbs, upholstery, cab fittings, and air-conditioning components. Additionally excluded is typical wear and tear from exposure to or contact with dangerous substances on materials like plastic, rubber, and exterior finishes.


  • John Deere offers a comprehensive 5-year or 5000 hours warranty on all its tractors, whichever is earlier than the date of its first sale.
  •  John Deere warranty is transferable to the second/ subsequent purchasers, if any, for the remaining duration within the overall warranty period.


In 1998, John Deere started doing business in India. Tractors were initially produced and sold by the company for export in India. John Deere can still operate successfully in India by trading in agricultural machinery and providing related services with a network of 19 local offices, 6 regional offices, and over 900 dealer touch points. Deere exports to more than 110 nations and has 4 training facilities spread over India. Pune serves as the country’s headquarters for John Deere tractors. In addition, the business operates eight locations in India for efficient manufacturing and service delivery.


Mahindra Tractors established a joint venture with International Harvester to make tractors under the Mahindra trademark for the Indian market. M&M created its first tractor, the Mahindra B-275, in 1963. Mahindra Tractors is one of the world’s top producers of tractors, selling over 85,000 units per year. The company also offers financing services to its customers.

  • Which are the best, John Deere or Mahindra tractors?

Both firms are industry leaders in their own right. Mahindra is the market leader in selling numerous tractors, all of which are in the low horsepower range. In contrast, John Deere is the market leader in giant, high-tech tractors. John Deere expanded in the US market before expanding to the rest of the world. It has created the most up-to-date technologies, from high-reliable products to precision agriculture. As the population continues to rise, agriculture must quickly develop high-tech, precise, innovative, and linked equipment to meet the demands for food and other outputs. 

  • Conclusion

Through deep research of both the industry-leading firms, it is clear that both have something essential to offer their customers. Whether it is their technologies or affordability, they are competitive in all. Choosing the best one will depend only on your required vehicle. We still hope that we were able to give you a deep understanding of the companies and assist you in making a much more informed decision. 

ghafari marketing is one of the best real estate agency located in pakistan that deal with socities like


The WittyFeed Triumph: Vinay Singhal, Parveen Singhal, and Shashank Vaishnav’s Journey to Content Dominance

Avatar photo



Vinay Singhal, Parveen Singhal, and Shashank Vaishnav have created a stunning success story with WittyFeed in the digital world, where content is king. Rising from the ashes of failed businesses, these computer experts changed course and built the second-largest content platform globally, only surpassed by BuzzFeed. This piece explores the story of these visionary founders and how WittyFeed rose to prominence in the content industry.

In 2013, faced with the setbacks of two unsuccessful ventures, Vinay, Parveen, and Shashank decided to stay the course. Ditching and FollowMe247, they envisioned a content platform that catered to the needs of content creators, distributors, and consumers. This vision materialized in September 2014 with the launch of WittyFeed—a platform that rapidly ascended the ranks to become the third-most visited website in the Indian entertainment category.

For Vinay Singhal, WittyFeed is not just a content platform; it’s a technology play. Leveraging robust technology and analytics, WittyFeed ensures its content goes viral by intricately guiding content selection, creation, distribution, and monetization. Real-time data analysis and insights into user behavior empower thousands of influencers to disseminate content, making WittyFeed a formidable player in the global content arena.

WittyFeed’s strategic foresight extends to its strong network of influencers, positioning the platform years ahead of its competitors. Recognizing influencers as the distributors in the digital world, WittyFeed created—an influencer platform with around 15,000 influencers. These influencers, with millions of followers, redirect traffic to WittyFeed, creating a symbiotic relationship that propels the platform’s reach.

WittyFeed’s impact transcends borders, with a presence in Spain, the US, and the UK, while rapidly gaining traction in India. The platform boasts over 100 million sessions and 60 million unique visitors monthly, generating revenues of ₹30 crore in FY17. Programmatic advertising forms a significant revenue stream, complemented by sponsored content collaborations with around 70 brands, including Uber, Coca-Cola, and Zee Studios. By endearing itself to brands, WittyFeed aims to derive 40 percent of its revenues from brand partnerships.

While WittyFeed has thrived, the platform remains vigilant about potential challenges, especially as Facebook’s algorithms evolve. Vinay emphasizes the importance of steering clear of click-bait and focusing on quality content to maintain a symbiotic relationship with Facebook. Future strategies include the integration of video content, fostering collaborations with mobile apps, and seeking a series A funding round for expansion.

The success of WittyFeed lies in the synergy of its founders—Parveen Singhal, Vinay Singhal, and Shashank Vaishnav. Parveen, the Chief Content Officer, envisions video content as the next growth frontier. Vinay, with a knack for building solutions, steers the technology-driven aspects, while Shashank, the Chief Technology Officer, brings real-time data analytics to the forefront.

As WittyFeed charts a course toward greater heights, its founders remain attuned to the evolving nature of digital consumption. Vinay Singhal encapsulates the essence of their journey, emphasizing the imperative of staying at the forefront of change. The triumvirate’s journey from the brink of failure to commanding one of the world’s largest content platforms is not just a success story; it’s a testament to resilience, innovation, and the power of strategic vision. In an ever-evolving digital landscape, WittyFeed and its founders stand poised for continued impact and influence.

Continue Reading


Rahul Narang and Saurabh Arora: Architects of Healthcare Transformation at Lybrate

Avatar photo



Rahul Narang and Saurabh Arora‘s combined genius is evident in the rapidly changing field of healthcare innovation as they lead Lybrate, a ground-breaking online platform for medical consultations. The story takes place against the backdrop of Saurabh Arora, who attended Columbia Business School and IIT Delhi before purposefully changing his course. 2014 saw Arora leave his position as a data scientist at Facebook in Silicon Valley in order to pursue his homegrown business goals. This crucial choice launched Lybrate in 2015, a platform that has the potential to completely transform patient-doctor relations.

Arora’s vision for Lybrate germinated during a visit to India, where he keenly observed the challenges posed by self-medication in rural areas and the inconveniences faced by urban denizens. Fueled by a determination to bridge these gaps, Arora enlisted the expertise of his former colleague and friend, Rahul Narang, who assumed the role of co-founder and chief technology officer at Lybrate.

The platform, operating as an online out-patient department (OPD), strategically deploys technology to enhance the accessibility of quality healthcare across India. Arora’s mission was to seamlessly connect patients and doctors, transcending geographical constraints. In less than three years, Lybrate has garnered over 1 lakh registered doctors, facilitating upwards of 6 million interactions monthly. These interactions span doctor searches, health queries, and appointments for consultations and lab tests.

The triumph of Lybrate can be attributed to its innovative approach and meticulous planning. Arora underscores the critical importance of aligning the product with the workflow of doctors, fostering positive word-of-mouth recommendations. The nascent stages involved securing funding, with Gokul Rajaram, a luminary in developing Google’s AdSense network, playing a pivotal role. Lybrate secured a seed round of $1.23 million from Nexus Venture Partners, Rajaram, and independent investor Vispi Daver in August 2014. A subsequent funding round in July 2015 saw a commitment of $10.2 million from Tiger Global, Nexus Venture Partners, and Ratan Tata, propelling Lybrate’s mission to new heights.

The healthcare landscape in India presents a formidable challenge, marked by a concerning doctor-patient ratio of 1:1,700, as highlighted by a joint report from KPMG and Ficci. What sets Lybrate apart is its unwavering focus on alleviating the doctor shortage. The platform’s workflow begins with anonymous health-related queries from patients, evolving into online or offline consultations as comfort levels with the doctors on the platform grow.

Lybrate’s distinctive patient engagement model places the patient at the center, offering access to a comprehensive spectrum of healthcare services. This strategic differentiator positions Lybrate favorably against Practo, its major competitor, which primarily functions as a doctor discovery platform. While Practo concentrates on appointment scheduling, Lybrate is committed to transforming the patient-doctor interaction and propelling it into the digital realm.

Despite the myriad challenges, Lybrate has achieved a commendable turnover of over ₹22.45 crore in FY15-16, with aspirations to reach ₹25 crore in the current fiscal year. The platform boasts various revenue streams, including ‘Lybrate Consult,’ allowing users to consult preferred doctors for a fee. ‘Lybrate Lab+’ and ‘Lybrate Cube’ contribute significantly to the company’s revenue by facilitating lab tests and providing tools for doctors to enhance their online presence.

As the health tech industry witnesses an influx of competitors, Lybrate’s early entry into the fray positions it as a frontrunner. However, challenges persist, and success in this dynamic landscape hinges on delivering a substantial value proposition for both patients and doctors. The journey of Rahul Narang and Saurabh Arora with Lybrate symbolizes a commitment to quality and innovation, marking the advent of a new era in online healthcare solutions.

Continue Reading


Abhishek Shah: Revolutionizing Diabetes Care Through Digital Therapeutics

Avatar photo



Abhishek Shah, the 34-year-old CEO of Mumbai-based Wellthy Therapeutics, stands out as an innovator in a world where chronic illnesses like type 2 diabetes are becoming more prevalent. With its AI-powered smartphone app that provides a customised health coach experience, Wellthy Therapeutics aims to revolutionise the treatment of type 2 diabetes. The journey of Abhishek Shah, the founding of Wellthy, and the significant influence it has had on patients such as Smruti Daru are all covered in this article.

Abhishek Shah’s foray into healthcare entrepreneurship was inspired by personal experiences. Growing up in a family of healthcare entrepreneurs, with parents diagnosed with chronic diseases, Shah witnessed the challenges of managing conditions like hypertension and diabetes. This exposure laid the foundation for Wellthy Therapeutics, founded in 2015 with the vision of leveraging technology for behavioral change in healthcare.

Wellthy Therapeutics’ mobile app serves as a personal health coach, utilizing AI to analyze patient data and habits. The app provides continuous guidance and motivation for adopting healthier lifestyle choices, crucial for managing type 2 diabetes. For individuals like Smruti Daru, the app has been transformative, helping her achieve significant improvements in glycated haemoglobin levels and weight within a short period.

At the core of Wellthy’s philosophy is an outcome-focused approach. Abhishek Shah emphasizes the importance of improving patient outcomes by addressing behavioral changes. The app guides patients through their daily routines, encouraging them to log diet, monitor sugar levels, track weight, and adhere to exercise routines. This focus on quantifiable outcomes sets Wellthy apart in the realm of digital therapeutics.

Wellthy Therapeutics has garnered recognition and endorsements from major organizations. Partnering with the Research Society for the Study of Diabetes in India (RSSDI) in 2016, Wellthy became a prescribed application for doctors. The company presented positive clinical outcomes at an American Diabetes Association conference, establishing itself as the first South Asian digital therapeutics firm with such achievements. Understanding the unique cultural nuances of India and Asia, Wellthy tailored its app to cater specifically to the genetic makeup, behavior, and values prevalent in the region. Recognizing that two-thirds of the world’s diabetics reside in Asia, Wellthy’s regional focus positions it strategically in the fight against diabetes.

Abhishek Shah’s commitment to improving healthcare outcomes is reflected in Wellthy’s self-funded growth. Investing around ₹2.9 crore into the venture, Shah prioritized creating a product that genuinely benefited patients. Wellthy’s expansion involves unique partnerships with hospitals, doctors, patients, and insurance companies, laying the groundwork for future growth. With plans to go live in the Middle East later this year, Wellthy envisions achieving a full-fledged presence in Asia within four to five years. The company’s trajectory aligns with its mission to redefine diabetes care through innovative technology and a patient-centric approach.

For Abhishek Shah, the journey of building Wellthy intertwines with the personal milestone of becoming a father. This balancing act, navigating the realms of first-generation entrepreneurship and first-time fatherhood, shattered perceived limitations and unlocked newfound capabilities. Shah’s dedication to his vision has not only transformed his life but has become a source of empowerment for individuals managing diabetes.

Continue Reading